US 12,233,039 B2
Memory in subjects with mini-mental state examination of 24-26
Patrick Joseph Gerardus Hendrikus Kamphuis, Utrecht (NL); Martine Groenendijk, Barendrecht (NL); and Anke Bongers, Veenendaal (NL)
Assigned to N.V. Nutricia, Zoetermeer (NL)
Filed by N.V. Nutricia, Zoetermeer (NL)
Filed on May 24, 2022, as Appl. No. 17/751,704.
Application 17/751,704 is a continuation of application No. 16/696,941, filed on Nov. 26, 2019, granted, now 11,395,810.
Application 16/696,941 is a continuation of application No. 12/666,611, abandoned, previously published as PCT/NL2008/050411, filed on Jun. 20, 2008.
Claims priority of application No. PCT/NL2007/050306 (WO), filed on Jun. 26, 2007; application No. PCT/NL2007/050307 (WO), filed on Jun. 26, 2007; application No. PCT/NL2007/050310 (WO), filed on Jun. 27, 2007; application No. 07123811 (EP), filed on Dec. 20, 2007; and application No. PCT/NL2008/050124 (WO), filed on Mar. 4, 2008.
Prior Publication US 2022/0280466 A1, Sep. 8, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/202 (2006.01); A23L 33/00 (2016.01); A23L 33/10 (2016.01); A23L 33/12 (2016.01); A23L 33/15 (2016.01); A23L 33/16 (2016.01); A61K 31/14 (2006.01); A61K 31/557 (2006.01); A61K 31/7072 (2006.01); A61K 45/06 (2006.01); A61P 25/28 (2006.01)
CPC A61K 31/202 (2013.01) [A23L 33/10 (2016.08); A23L 33/12 (2016.08); A23L 33/15 (2016.08); A23L 33/16 (2016.08); A23L 33/40 (2016.08); A61K 31/14 (2013.01); A61K 31/557 (2013.01); A61K 31/7072 (2013.01); A61K 45/06 (2013.01); A61P 25/28 (2018.01); A23V 2002/00 (2013.01)] 11 Claims
 
1. An enteral composition comprising:
(a) uridine or uridine phosphate,
(b) docosahexaenoic acid (DHA),
(c) eicosapentaenoic acid (EPA),
(d) phospholipids and/or choline,
(e) vitamin B12, and
(f) folic acid.